167 related articles for article (PubMed ID: 27234618)
1. Plasma Amyloid Beta 1-42 and DNA Methylation Pattern Predict Accelerated Aging in Young Subjects with Down Syndrome.
Obeid R; Hübner U; Bodis M; Geisel J
Neuromolecular Med; 2016 Dec; 18(4):593-601. PubMed ID: 27234618
[TBL] [Abstract][Full Text] [Related]
2. Effect of adding B-vitamins to vitamin D and calcium supplementation on CpG methylation of epigenetic aging markers.
Obeid R; Hübner U; Bodis M; Graeber S; Geisel J
Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):411-417. PubMed ID: 29395637
[TBL] [Abstract][Full Text] [Related]
3. Accelerated epigenetic aging in Down syndrome.
Horvath S; Garagnani P; Bacalini MG; Pirazzini C; Salvioli S; Gentilini D; Di Blasio AM; Giuliani C; Tung S; Vinters HV; Franceschi C
Aging Cell; 2015 Jun; 14(3):491-5. PubMed ID: 25678027
[TBL] [Abstract][Full Text] [Related]
4. Blood biomarkers of methylation in Down syndrome and metabolic simulations using a mathematical model.
Obeid R; Hartmuth K; Herrmann W; Gortner L; Rohrer TR; Geisel J; Reed MC; Nijhout HF
Mol Nutr Food Res; 2012 Oct; 56(10):1582-9. PubMed ID: 22930479
[TBL] [Abstract][Full Text] [Related]
5. Plasma amyloid-β as a function of age, level of intellectual disability, and presence of dementia in Down syndrome.
Head E; Doran E; Nistor M; Hill M; Schmitt FA; Haier RJ; Lott IT
J Alzheimers Dis; 2011; 23(3):399-409. PubMed ID: 21116050
[TBL] [Abstract][Full Text] [Related]
6. Developing a DNA methylation assay for human age prediction in blood and bloodstain.
Huang Y; Yan J; Hou J; Fu X; Li L; Hou Y
Forensic Sci Int Genet; 2015 Jul; 17():129-136. PubMed ID: 25979242
[TBL] [Abstract][Full Text] [Related]
7. Plasma amyloid and tau as dementia biomarkers in Down syndrome: Systematic review and meta-analyses.
Alhajraf F; Ness D; Hye A; Strydom A
Dev Neurobiol; 2019 Jul; 79(7):684-698. PubMed ID: 31389176
[TBL] [Abstract][Full Text] [Related]
8. Plasma amyloid beta protein 1-42 levels are increased in old Down Syndrome but not in young Down Syndrome.
Mehta PD; Mehta SP; Fedor B; Patrick BA; Emmerling M; Dalton AJ
Neurosci Lett; 2003 May; 342(3):155-8. PubMed ID: 12757888
[TBL] [Abstract][Full Text] [Related]
9. Aging of blood can be tracked by DNA methylation changes at just three CpG sites.
Weidner CI; Lin Q; Koch CM; Eisele L; Beier F; Ziegler P; Bauerschlag DO; Jöckel KH; Erbel R; Mühleisen TW; Zenke M; Brümmendorf TH; Wagner W
Genome Biol; 2014 Feb; 15(2):R24. PubMed ID: 24490752
[TBL] [Abstract][Full Text] [Related]
10. Accelerated epigenetic aging in newborns with Down syndrome.
Xu K; Li S; Muskens IS; Elliott N; Myint SS; Pandey P; Hansen HM; Morimoto LM; Kang AY; Ma X; Metayer C; Mueller BA; Roberts I; Walsh KM; Horvath S; Wiemels JL; de Smith AJ
Aging Cell; 2022 Jul; 21(7):e13652. PubMed ID: 35661546
[TBL] [Abstract][Full Text] [Related]
11. DNA Hydroxymethylation Levels Are Altered in Blood Cells From Down Syndrome Persons Enrolled in the MARK-AGE Project.
Ciccarone F; Valentini E; Malavolta M; Zampieri M; Bacalini MG; Calabrese R; Guastafierro T; Reale A; Franceschi C; Capri M; Breusing N; Grune T; Moreno-Villanueva M; Bürkle A; Caiafa P
J Gerontol A Biol Sci Med Sci; 2018 May; 73(6):737-744. PubMed ID: 29069286
[TBL] [Abstract][Full Text] [Related]
12. Down Syndrome, Ageing and Epigenetics.
Gensous N; Franceschi C; Salvioli S; Garagnani P; Bacalini MG
Subcell Biochem; 2019; 91():161-193. PubMed ID: 30888653
[TBL] [Abstract][Full Text] [Related]
13. Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome.
Tatebe H; Kasai T; Ohmichi T; Kishi Y; Kakeya T; Waragai M; Kondo M; Allsop D; Tokuda T
Mol Neurodegener; 2017 Sep; 12(1):63. PubMed ID: 28866979
[TBL] [Abstract][Full Text] [Related]
14. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
Mehta PD; Capone G; Jewell A; Freedland RL
J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic age predictions based on buccal swabs are more precise in combination with cell type-specific DNA methylation signatures.
Eipel M; Mayer F; Arent T; Ferreira MR; Birkhofer C; Gerstenmaier U; Costa IG; Ritz-Timme S; Wagner W
Aging (Albany NY); 2016 May; 8(5):1034-48. PubMed ID: 27249102
[TBL] [Abstract][Full Text] [Related]
16. Lumbar cerebrospinal fluid choline in healthy aging and in Down's syndrome.
Schapiro MB; Atack JR; Hanin I; May C; Haxby JV; Rapoport SI
Arch Neurol; 1990 Sep; 47(9):977-80. PubMed ID: 2144417
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma amyloid beta protein 1-42 levels in Down syndrome.
Mehta PD; Dalton AJ; Mehta SP; Kim KS; Sersen EA; Wisniewski HM
Neurosci Lett; 1998 Jan; 241(1):13-6. PubMed ID: 9502204
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte glycohydrolases in subjects with trisomy 21: could Down's syndrome be a model of accelerated ageing?
Massaccesi L; Corsi MM; Baquero-Herrera CJ; Licastro F; Tringali C; Venerando B; Lombardo A; Alberghino A; Goi G
Mech Ageing Dev; 2006 Apr; 127(4):324-31. PubMed ID: 16460783
[TBL] [Abstract][Full Text] [Related]
19. Improved age determination of blood and teeth samples using a selected set of DNA methylation markers.
Bekaert B; Kamalandua A; Zapico SC; Van de Voorde W; Decorte R
Epigenetics; 2015; 10(10):922-30. PubMed ID: 26280308
[TBL] [Abstract][Full Text] [Related]
20. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
